BIOEX Bioextrax AB (publ)

0.2559USD2.600 SEK · STO+0.39%Mkt Cap: 12.20M USDP/E: —

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based p…

Key Statistics

Company
Market Cap12.20M USD
Enterprise Value11.45M USD
Revenue (TTM)100.79K USD
Gross Profit-49.31K USD
Net Income (TTM)-1.74M USD
Revenue/Share0.0024 USD
Last Price0.2559 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14
CountrySE
SectorIndustrials
IndustryWaste Management
ISINSE0016276752
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.60
EV/Revenue113.65
P/S121.03
P/B10.32
EPS (TTM)-0.04 USD
EPS (Forward)—
52W Range
0.157550% of range0.3543
52W High0.3543 USD
52W Low0.1575 USD
Profitability
Gross Margin-66.18%
Oper. Margin-1824.32%
EBITDA Margin0.00%
Profit Margin-2338.84%
ROE-83.46%
ROA-71.60%
ROIC—
ROCE-84.09%
Growth
Revenue Growth-55.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.56M USD
CapEx (TTM)14.96K USD
FCF Margin-974.93%
FCF Yield-8.06%
Net Debt-727.49K USD
Net Debt/EBITDA0.42
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio3.53
Quick Ratio3.10
Book Value/Sh0.02 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.47.67M
Float39.27M
Insiders21.81%
Institutions22.59%
Technical
SMA 500.2300 (+11.3%)
SMA 2000.2498 (+2.4%)
Beta1.53
S&P 52W Chg12.00%
Avg Vol (30d)84.60K
Avg Vol (10d)101.79K
Technical Indicators
RSI (14)62.6
MACD0.0814
MACD Signal0.0521
MACD Hist.+0.0293
BB Upper0.2669 USD
BB Middle0.2346 USD
BB Lower0.2022 USD
BB Width27.59%
ATR (14)0.0211 USD
Vol Ratio (20d)0.67x

About Bioextrax (STO: BIOEX)

›

Bioextrax (STO: BIOEX) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Waste Management industry, part of the Industrials sector, and reports about 14 employees.

The shares were at 2.600 SEK on 19 November 2026, up 22.1% over 52 weeks. Its 52-week range is 1.600 SEK to 3.600 SEK: the price is 27.8% below the high and 62.5% above the low.

Its market capitalisation is 123.93M SEK.

Bioextrax reports return on equity of -83.5% and revenue down 55.4% year over year.

It holds more cash than debt, a net cash position of 7.39M SEK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.